Bioburden is the measure of living microbes on a surface that has not yet been sterilized. It is usually tested for on medical devices and other products that come in contact with patients during care at a medical facility.
This document discusses bioburden testing, which quantifies the number of microorganisms present on a medical device or pharmaceutical product. It outlines the purposes of bioburden testing such as acting as a quality control measure and determining necessary sterilization doses. The key steps of bioburden testing include sampling techniques, extraction methods, enumeration procedures like plate counting, and incubation. Regulations like CFR 21 and ISO 11737 provide standards for bioburden testing to ensure product quality and safety.
This document discusses two methods for validating the extraction efficiency of a bioburden test method: repetitive recovery and product inoculation. The repetitive recovery method involves repeatedly extracting microorganisms from a sample until no new organisms are recovered to determine the overall recovery rate. The product inoculation method involves inoculating a product with known microbes and calculating the recovery rate based on the inoculum amount and recovered amount. While product inoculation establishes a correction factor, the drying process can impact microbe viability, so repetitive recovery is generally preferred for determining bioburden extraction efficiency.
Understanding How Bioburden and Sterilization Affect Medical DevicesPacific BioLabs
1) Bioburden refers to microorganisms present on medical devices and must be monitored and controlled as high levels can compromise sterilization validation.
2) Sterilization methods like gamma, e-beam, and ethylene oxide are effective when bioburden levels are properly determined and accounted for in the sterilization dose.
3) Maintaining low and consistent bioburden through environmental monitoring, personnel training, cleaning processes, and device design is essential for ensuring sterilized medical devices.
The document discusses biosafety levels and biosafety cabinets. It defines the four biosafety levels from BSL-1 to BSL-4 based on the risk group of pathogens handled. It also explains the different types of biosafety cabinets (class I to III), how they provide varying levels of protection to the user, product and environment through HEPA filtration and pressure differentials, and standards for their design and testing.
Bioburden refers to the number of microorganisms contaminating a material prior to sterilization. Bioburden testing measures the total microbial count on medical devices before final sterilization and use. It is important for quality control and ensuring sterilization processes are effective at eliminating microbes. Routine bioburden testing helps manufacturers monitor for changes in contamination levels, identify process improvements, and maintain sterility assurance of their medical products.
The document provides an overview of microbial monitoring in a manufacturing area. It discusses:
1) The purpose of an environmental monitoring program is to provide crucial information on the quality of the aseptic processing environment during manufacturing and to prevent the release of contaminated batches.
2) Microbial monitoring tests for viable and non-viable particles in critical areas like cleanrooms, tank rooms, and packaging areas to demonstrate control of microorganisms.
3) Sources of contamination can come from air, personnel, equipment, cleaning agents and more. Monitoring must meet regulatory standards from agencies like FDA, ISO, and USP.
This document discusses bioburden testing, which quantifies the number of microorganisms present on a medical device or pharmaceutical product. It outlines the purposes of bioburden testing such as acting as a quality control measure and determining necessary sterilization doses. The key steps of bioburden testing include sampling techniques, extraction methods, enumeration procedures like plate counting, and incubation. Regulations like CFR 21 and ISO 11737 provide standards for bioburden testing to ensure product quality and safety.
This document discusses two methods for validating the extraction efficiency of a bioburden test method: repetitive recovery and product inoculation. The repetitive recovery method involves repeatedly extracting microorganisms from a sample until no new organisms are recovered to determine the overall recovery rate. The product inoculation method involves inoculating a product with known microbes and calculating the recovery rate based on the inoculum amount and recovered amount. While product inoculation establishes a correction factor, the drying process can impact microbe viability, so repetitive recovery is generally preferred for determining bioburden extraction efficiency.
Understanding How Bioburden and Sterilization Affect Medical DevicesPacific BioLabs
1) Bioburden refers to microorganisms present on medical devices and must be monitored and controlled as high levels can compromise sterilization validation.
2) Sterilization methods like gamma, e-beam, and ethylene oxide are effective when bioburden levels are properly determined and accounted for in the sterilization dose.
3) Maintaining low and consistent bioburden through environmental monitoring, personnel training, cleaning processes, and device design is essential for ensuring sterilized medical devices.
The document discusses biosafety levels and biosafety cabinets. It defines the four biosafety levels from BSL-1 to BSL-4 based on the risk group of pathogens handled. It also explains the different types of biosafety cabinets (class I to III), how they provide varying levels of protection to the user, product and environment through HEPA filtration and pressure differentials, and standards for their design and testing.
Bioburden refers to the number of microorganisms contaminating a material prior to sterilization. Bioburden testing measures the total microbial count on medical devices before final sterilization and use. It is important for quality control and ensuring sterilization processes are effective at eliminating microbes. Routine bioburden testing helps manufacturers monitor for changes in contamination levels, identify process improvements, and maintain sterility assurance of their medical products.
The document provides an overview of microbial monitoring in a manufacturing area. It discusses:
1) The purpose of an environmental monitoring program is to provide crucial information on the quality of the aseptic processing environment during manufacturing and to prevent the release of contaminated batches.
2) Microbial monitoring tests for viable and non-viable particles in critical areas like cleanrooms, tank rooms, and packaging areas to demonstrate control of microorganisms.
3) Sources of contamination can come from air, personnel, equipment, cleaning agents and more. Monitoring must meet regulatory standards from agencies like FDA, ISO, and USP.
The document discusses biosafety levels (BSL) for working with biological agents in laboratories. It describes the four BSL levels from 1 to 4, with 1 being the lowest risk and 4 being the highest risk. For each BSL level, it provides details on the types of agents used, standard practices, safety equipment requirements, and facilities. It also discusses the concepts of primary and secondary barriers for biocontainment.
The document discusses biosafety levels (BSL) which are used to classify biological agents based on risk. There are four biosafety levels, with BSL-1 posing the lowest risk (ex. E. coli bacteria) and BSL-4 posing the highest risk (ex. Ebola virus). Each level has specific containment controls for laboratory practices, safety equipment, and facility construction required to safely work with the biological agents in that risk group. The summary outlines some of the key containment controls like personal protective equipment, biological safety cabinets, and facility access restrictions that distinguish the different biosafety levels.
Updates to the Bioburden Standard ISO 11737-1; significant additional guidanc...UBMCanon
This document discusses updates being made to ISO 11737-1, the international standard for bioburden testing. It notes that microbiologists are less commonly employed directly by medical device companies now. This can lead to less expertise in critical areas like sterilization validation. The document advocates including knowledgeable microbiologists in product design and process validation decisions. It also provides guidance on challenges like low bioburden testing, sample pooling, atypical bioburden results, and updates being made to the standard to address these issues.
To maintain the desired SAL at the plant is task which demands great care and control over Man, Machine & Method. This summarize work will definitely help you as hand note.
A biological indicator is a standardized preparation of viable microorganisms, usually bacterial spores, that is carried either directly by some of the items to be sterilized or by carriers such as filter papers, porcelain cylinders, that serve as a challenge to the effectiveness of a given sterilization cycle
This document discusses various methods for testing the efficacy of disinfectants, including carrier tests, suspension tests, and practical tests. Carrier tests involve contaminating carriers like threads with bacteria and exposing them to disinfectants. Suspension tests involve exposing a bacterial suspension directly to the disinfectant. Practical tests evaluate disinfectants under real-world conditions. The document also describes factors that can influence disinfection like temperature, pH, and the presence of organic matter or other substances. Specific tests discussed in detail include the AOAC use-dilution test, Kelsey-Sykes capacity test, and surface disinfection tests.
This document discusses microbiology activities related to sterility assurance for pharmaceutical products. It outlines the microbiological testing done on raw materials, processes, water systems, environments and finished products. This includes bioburden testing, pathogen testing, endotoxin testing, and sterility testing. It also discusses environmental monitoring programs for sterile facilities and aseptic filling areas. Key requirements outlined include pre-filtration bioburden limits, media fill qualifications, aseptic process simulations, and staff performance monitoring. Recent issues with increased out of limit environmental monitoring results are also summarized.
Sterility Testing is defined as a testing which confirms that products are free from the presence of viable microorganisms. Sterility testing is very important for medical devices, pharmaceuticals, preparations, tissue materials and other materials that claim to be sterile or free from viable microorganisms.
This document discusses biological safety cabinets (BSCs), which are intended to protect laboratory workers from aerosols and airborne particles. It describes the three classes of BSCs - Class I, II, and III - and their varying degrees of protection. Class I BSCs protect the worker, Class II protect the worker and environment, and Class III protect the worker, environment, and product. The key features of each class are explained, including HEPA filtration and air flow patterns. Proper use and maintenance of BSCs is also covered.
The document discusses three main methods for the bacterial endotoxin test - gel clot, turbidimetric, and chromogenic. The gel clot method is the simplest but least quantitative, while turbidimetric and chromogenic methods allow for more automation and precision using spectrophotometry. All three methods use Limulus amebocyte lysate and detect endotoxins through coagulation reactions. The choice of method depends on factors like testing volumes, sample properties, required sensitivity, and compliance needs. Photometric methods have advantages of automation and precision but higher costs, while gel clot is inexpensive but less quantitative.
This document discusses microbiological air sampling methods used in quality control laboratories. It describes two primary sampling methods: active monitoring which uses air samplers to force air into collection plates, and passive monitoring which uses open collection plates exposed to ambient air. Specific active monitoring methods discussed include impactors which accelerate air onto plates, sieve samplers with stacked perforated plates, and centrifugal samplers. Gelatin membrane filtration is also covered as it can reliably capture viruses. Maintaining sample integrity and accurately measuring air volumes are challenges addressed.
The document discusses environmental monitoring programs in clean rooms and aseptic processing areas. It describes the purpose of monitoring to control microbial and particle contamination and prevent release of contaminated products. Key aspects covered include viable and non-viable monitoring of air, surfaces, personnel and drains using methods like air sampling, surface swabbing and particle counting. It provides classification standards and action limits for contamination and validation procedures for HVAC systems. Personnel are identified as the main challenge to control in aseptic processing.
This document provides guidelines for safety in microbiological laboratories. It outlines various means through which laboratory infections can occur, such as through aerosols, contaminated surfaces, and accidents involving needles or broken glass. It recommends personal protective equipment, biological safety cabinets, proper ventilation, and restricted access for high-risk areas. The responsibilities of the safety officer and importance of training personnel are discussed. Procedures for proper hygiene, disposal of contaminated materials, and different containment levels are also outlined.
This document discusses biofilm in endodontics. It defines biofilm as a community of microorganisms attached to a surface and embedded in a self-produced matrix. The document covers the ultrastructure of biofilm, its characteristics, development, and how it provides protection and benefits to microbes. Biofilm formation involves initial attachment, growth and maturation of microcolonies, and dispersion. Quorum sensing allows for genetic exchange between bacteria in biofilm. Due to its structure and physiology, biofilm exhibits high resistance to antimicrobial agents.
The document discusses biohazards and outlines procedures for ensuring environmental safety when working with biological materials. It defines biohazards as biological substances that threaten human health, such as viruses, bacteria, and toxins. Different levels of biocontainment are used depending on the risk level of the pathogens being handled, with Level 1 requiring minimal precautions and Level 4 the highest level of isolation for dangerous pathogens lacking vaccines or treatments. Proper use of warning signs, protective equipment, sterilization processes, and segregated work areas are emphasized for reducing risks of exposure or contamination.
Sterility testing attempts to determine if viable microorganisms are present in pharmaceutical products by testing samples from a batch. It is done after sterilization but cannot guarantee sterility of the entire batch. Major factors that can affect the results are the testing environment, culture conditions, sampling procedure, and test method used. Common test methods include membrane filtration and direct inoculation into culture media like fluid thioglycollate and soya-bean casein digest media. Observation over the incubation period can indicate if the test and batch pass or fail sterility requirements. Guidelines stress the level of assurance depends on manufacturing conditions and batch homogeneity.
This document provides a summary of guidance from the World Health Organization (WHO) on good practices for pharmaceutical microbiology laboratories. It was compiled by Drug Regulations, a non-profit organization that provides online resources for pharmaceutical professionals. The guidance covers topics such as personnel qualifications, laboratory design, equipment calibration, test method validation, and environmental monitoring of sterility testing facilities.
Alert Action and Specification Limits for Bioburden and Endotoxin - SK26Feb15...Stephan O. Krause, PhD
The document discusses setting alert and action levels for bioburden and endotoxin levels during biologics manufacturing. It describes using a quality risk management process like FMEA to establish risk-based alert and action levels during clinical and early commercial stages when historical data is limited. For later stages when more data is available, levels can be set statistically based on actual process capability and performance. The document provides an example of revising drug substance specifications and establishing alert and action levels for bioburden and endotoxin throughout development and commercial manufacturing.
This document provides procedures for conducting a Microbial Limit Test (MLT). The test involves several steps: sample pretreatment, total aerobic count using membrane filtration or plate count methods, and examination for specified microorganisms like E. coli, Salmonella, Pseudomonas aeruginosa, and Staphylococcus aureus. Positive and negative controls are run alongside each test. The procedures describe preparing bacterial and fungal suspensions, inoculating various media, and incubating and examining plates to identify microbial growth or absence. Safety precautions like using clean gloves and running tests under laminar airflow are also outlined.
The document discusses biosafety levels (BSL) for working with biological agents in laboratories. It describes the four BSL levels from 1 to 4, with 1 being the lowest risk and 4 being the highest risk. For each BSL level, it provides details on the types of agents used, standard practices, safety equipment requirements, and facilities. It also discusses the concepts of primary and secondary barriers for biocontainment.
The document discusses biosafety levels (BSL) which are used to classify biological agents based on risk. There are four biosafety levels, with BSL-1 posing the lowest risk (ex. E. coli bacteria) and BSL-4 posing the highest risk (ex. Ebola virus). Each level has specific containment controls for laboratory practices, safety equipment, and facility construction required to safely work with the biological agents in that risk group. The summary outlines some of the key containment controls like personal protective equipment, biological safety cabinets, and facility access restrictions that distinguish the different biosafety levels.
Updates to the Bioburden Standard ISO 11737-1; significant additional guidanc...UBMCanon
This document discusses updates being made to ISO 11737-1, the international standard for bioburden testing. It notes that microbiologists are less commonly employed directly by medical device companies now. This can lead to less expertise in critical areas like sterilization validation. The document advocates including knowledgeable microbiologists in product design and process validation decisions. It also provides guidance on challenges like low bioburden testing, sample pooling, atypical bioburden results, and updates being made to the standard to address these issues.
To maintain the desired SAL at the plant is task which demands great care and control over Man, Machine & Method. This summarize work will definitely help you as hand note.
A biological indicator is a standardized preparation of viable microorganisms, usually bacterial spores, that is carried either directly by some of the items to be sterilized or by carriers such as filter papers, porcelain cylinders, that serve as a challenge to the effectiveness of a given sterilization cycle
This document discusses various methods for testing the efficacy of disinfectants, including carrier tests, suspension tests, and practical tests. Carrier tests involve contaminating carriers like threads with bacteria and exposing them to disinfectants. Suspension tests involve exposing a bacterial suspension directly to the disinfectant. Practical tests evaluate disinfectants under real-world conditions. The document also describes factors that can influence disinfection like temperature, pH, and the presence of organic matter or other substances. Specific tests discussed in detail include the AOAC use-dilution test, Kelsey-Sykes capacity test, and surface disinfection tests.
This document discusses microbiology activities related to sterility assurance for pharmaceutical products. It outlines the microbiological testing done on raw materials, processes, water systems, environments and finished products. This includes bioburden testing, pathogen testing, endotoxin testing, and sterility testing. It also discusses environmental monitoring programs for sterile facilities and aseptic filling areas. Key requirements outlined include pre-filtration bioburden limits, media fill qualifications, aseptic process simulations, and staff performance monitoring. Recent issues with increased out of limit environmental monitoring results are also summarized.
Sterility Testing is defined as a testing which confirms that products are free from the presence of viable microorganisms. Sterility testing is very important for medical devices, pharmaceuticals, preparations, tissue materials and other materials that claim to be sterile or free from viable microorganisms.
This document discusses biological safety cabinets (BSCs), which are intended to protect laboratory workers from aerosols and airborne particles. It describes the three classes of BSCs - Class I, II, and III - and their varying degrees of protection. Class I BSCs protect the worker, Class II protect the worker and environment, and Class III protect the worker, environment, and product. The key features of each class are explained, including HEPA filtration and air flow patterns. Proper use and maintenance of BSCs is also covered.
The document discusses three main methods for the bacterial endotoxin test - gel clot, turbidimetric, and chromogenic. The gel clot method is the simplest but least quantitative, while turbidimetric and chromogenic methods allow for more automation and precision using spectrophotometry. All three methods use Limulus amebocyte lysate and detect endotoxins through coagulation reactions. The choice of method depends on factors like testing volumes, sample properties, required sensitivity, and compliance needs. Photometric methods have advantages of automation and precision but higher costs, while gel clot is inexpensive but less quantitative.
This document discusses microbiological air sampling methods used in quality control laboratories. It describes two primary sampling methods: active monitoring which uses air samplers to force air into collection plates, and passive monitoring which uses open collection plates exposed to ambient air. Specific active monitoring methods discussed include impactors which accelerate air onto plates, sieve samplers with stacked perforated plates, and centrifugal samplers. Gelatin membrane filtration is also covered as it can reliably capture viruses. Maintaining sample integrity and accurately measuring air volumes are challenges addressed.
The document discusses environmental monitoring programs in clean rooms and aseptic processing areas. It describes the purpose of monitoring to control microbial and particle contamination and prevent release of contaminated products. Key aspects covered include viable and non-viable monitoring of air, surfaces, personnel and drains using methods like air sampling, surface swabbing and particle counting. It provides classification standards and action limits for contamination and validation procedures for HVAC systems. Personnel are identified as the main challenge to control in aseptic processing.
This document provides guidelines for safety in microbiological laboratories. It outlines various means through which laboratory infections can occur, such as through aerosols, contaminated surfaces, and accidents involving needles or broken glass. It recommends personal protective equipment, biological safety cabinets, proper ventilation, and restricted access for high-risk areas. The responsibilities of the safety officer and importance of training personnel are discussed. Procedures for proper hygiene, disposal of contaminated materials, and different containment levels are also outlined.
This document discusses biofilm in endodontics. It defines biofilm as a community of microorganisms attached to a surface and embedded in a self-produced matrix. The document covers the ultrastructure of biofilm, its characteristics, development, and how it provides protection and benefits to microbes. Biofilm formation involves initial attachment, growth and maturation of microcolonies, and dispersion. Quorum sensing allows for genetic exchange between bacteria in biofilm. Due to its structure and physiology, biofilm exhibits high resistance to antimicrobial agents.
The document discusses biohazards and outlines procedures for ensuring environmental safety when working with biological materials. It defines biohazards as biological substances that threaten human health, such as viruses, bacteria, and toxins. Different levels of biocontainment are used depending on the risk level of the pathogens being handled, with Level 1 requiring minimal precautions and Level 4 the highest level of isolation for dangerous pathogens lacking vaccines or treatments. Proper use of warning signs, protective equipment, sterilization processes, and segregated work areas are emphasized for reducing risks of exposure or contamination.
Sterility testing attempts to determine if viable microorganisms are present in pharmaceutical products by testing samples from a batch. It is done after sterilization but cannot guarantee sterility of the entire batch. Major factors that can affect the results are the testing environment, culture conditions, sampling procedure, and test method used. Common test methods include membrane filtration and direct inoculation into culture media like fluid thioglycollate and soya-bean casein digest media. Observation over the incubation period can indicate if the test and batch pass or fail sterility requirements. Guidelines stress the level of assurance depends on manufacturing conditions and batch homogeneity.
This document provides a summary of guidance from the World Health Organization (WHO) on good practices for pharmaceutical microbiology laboratories. It was compiled by Drug Regulations, a non-profit organization that provides online resources for pharmaceutical professionals. The guidance covers topics such as personnel qualifications, laboratory design, equipment calibration, test method validation, and environmental monitoring of sterility testing facilities.
Alert Action and Specification Limits for Bioburden and Endotoxin - SK26Feb15...Stephan O. Krause, PhD
The document discusses setting alert and action levels for bioburden and endotoxin levels during biologics manufacturing. It describes using a quality risk management process like FMEA to establish risk-based alert and action levels during clinical and early commercial stages when historical data is limited. For later stages when more data is available, levels can be set statistically based on actual process capability and performance. The document provides an example of revising drug substance specifications and establishing alert and action levels for bioburden and endotoxin throughout development and commercial manufacturing.
This document provides procedures for conducting a Microbial Limit Test (MLT). The test involves several steps: sample pretreatment, total aerobic count using membrane filtration or plate count methods, and examination for specified microorganisms like E. coli, Salmonella, Pseudomonas aeruginosa, and Staphylococcus aureus. Positive and negative controls are run alongside each test. The procedures describe preparing bacterial and fungal suspensions, inoculating various media, and incubating and examining plates to identify microbial growth or absence. Safety precautions like using clean gloves and running tests under laminar airflow are also outlined.
This document provides a summary of the content areas and competencies tested on the Medical Laboratory Technician (MLT) certification examination. It is organized into six main sections: Blood Bank, Chemistry, Hematology, Microbiology, Urinalysis/Other Body Fluids, and Laboratory Operations. Each section lists the specific topics covered, such as blood typing and crossmatching in Blood Bank or electrolyte and protein testing in Chemistry. Competencies involve technical skills like performing laboratory tests, problem solving abnormal results, verifying quality control, and communicating with clinicians. The examination evaluates knowledge, interpretation, and problem-solving skills through multiple choice questions.
This document provides information on testing for sterility of parenterals using membrane filtration and direct inoculation methods. It describes two culture media used - Fluid Thioglycollate medium and Soybean-Casein Digest medium. The membrane filtration method is appropriate for aqueous, oily, and alcohol preparations. All steps are performed aseptically. Samples are filtered and media is incubated for 7-14 days. Observations are made for evidence of microbial growth to determine if the test passes for sterility.
A Risk-Based Approach for Investigating Environmental Monitoring ExcursionsRobert Westney
This document outlines a risk-based approach for investigating environmental monitoring excursions. It discusses elements of an investigation plan, key investigation points, root cause analysis, corrective actions, and assessing the impact on facilities and products. A risk-based approach considers the probability and severity of harm to determine appropriate corrective actions. Investigations should identify root causes and prevent recurrence by modifying procedures, training, or equipment. The potential impact on facilities and products is assessed based on historical data trends and control of manufacturing processes.
The document discusses the validation of water supply systems for pharmaceutical use. It outlines the validation process, which includes design qualification to verify the system design, installation qualification to confirm proper installation, operation qualification to test system functionality under static conditions, and performance qualification to demonstrate consistent performance over time under normal operating conditions. Routine monitoring, maintenance, and change control procedures are also required to ensure continued system operation and water quality as specified.
Sterilization Standards Update: Strategies for ComplianceMedTech Review, LLC
This document summarizes the key points of a presentation on sterilization requirements and strategies for compliance. The presentation covered general sterilization requirements, radiation sterilization and its impacts, and EO sterilization and its impacts. It discussed the main changes in ISO 11137 for radiation sterilization and ISO 11135 for EO sterilization, and the impacts these standards have on sterilization contractors and medical device manufacturers.
Overview of the pharmaceutical industry of bangladeshSadman Prodhan
The document provides an overview of the pharmaceutical industry in Bangladesh. It notes that the industry was established in 1950 and now includes 231 companies with a market size of 76.5 billion BDT. The top 5 companies by market share are Square, Incepta, Beximco, Opsonin, and Eskayef. The industry supplies 97% of the domestic market and exports to 72 countries. A PESTEL analysis identifies various political, economic, social, technological, environmental and legal factors impacting the industry. A Porter's 5 forces analysis finds high rivalry among existing firms and a very high threat of new entrants. The document also compares Square Pharmaceuticals and Orion Pharma in terms of market position,
The document discusses the validation of a water supply system for a pharmacy college. It outlines the objectives of validation to ensure consistent production of water meeting quality specifications. The validation process includes design qualification, installation qualification, operation qualification, and performance qualification to test the system under all expected operating conditions. Key steps involve defining quality attributes, developing a validation protocol and acceptance criteria, conducting testing and data collection, and documenting the validation results.
This document provides guidance on cleanroom classifications and air quality standards for the manufacture of sterile products. It outlines four grades (A, B, C, D) for clean areas based on required airborne particulate and microbial limits. Grade A is for high-risk operations like filling and requires laminar airflow. Grades B, C, D are for less critical processes. Air quality standards are provided for "at rest" and "in operation" states. Monitoring of clean areas during production is recommended to control particulate and microbial levels.
This document provides information on sterile products and admixtures. It discusses parenteral routes of administration such as subcutaneous, intramuscular, intravenous, and venoclysis. It describes the advantages and disadvantages of parenteral administration. It outlines the processing steps for parenteral products including cleaning, preparation, filtration, filling, sealing, sterilization, evaluation, labeling and packaging. It discusses various container and closure materials used and describes the formulation of parenteral products. It also summarizes the evaluation tests conducted on parenteral preparations including sterility, clarity, leakage, pyrogen and assay testing.
This document provides an overview of sterile dosage forms, including parenteral products and ophthalmic preparations. It discusses various routes of parenteral administration and key components of parenteral products such as antioxidants, buffers, and solvent systems. It also covers topics like containers and closures, formulation of solutions and suspensions, and sterilization methods. The document serves as a reference for professionals working with sterile dosage forms and parenteral drug delivery.
The document discusses pyrogen testing techniques including the rabbit test and LAL (Limulus Amebocyte Lysate) test. It provides details on how to conduct the rabbit test, including temperature monitoring and criteria for a passing result. For the LAL test, it describes the mechanism, different methods (gel clot, turbidimetric, chromogenic), and procedures for confirming lysate sensitivity and determining endotoxin levels in samples. It notes that various pharmacopeias like IP, BP, and USP specify methods for the LAL test.
Endotoxin Testing is performed to ensure that injectable preparations and medical devices are free from pyrogens and safe for human use.
Pyrogens constitute a heterogeneous group of fever causing substances which comprise both microbial and non-microbial substances. The most potent and most widely known are the endotoxins or lipopolysaccharides (LPS), which are cell wall components of gram-negative bacteria. Gram-positive bacteria are also sources of pyrogens, in particular lipoteichoic acid (LTA), as are particles from yeasts and viruses. Non-microbial pyrogens often emanate from production environments. Small particles of packaging materials are a typical example.
Biosaftey means the needs to protect human and animal health along with the environment from the possible adverse effects of the products of modern biotechnology. Biosafety defines the containment conditions under which infectious agents can be safely manipulated. Biosafety word is used to reduce and eliminate the potential risk regulating from the modern biotechnology and its products.
This document outlines regulations for safety in biological plants regarding biohazards and biosecurity. It defines key terms like biohazard, biosecurity, and biosafety. It discusses safety basics in biological plants including biosafety in the lab and personal biosafety. It covers national regulations in India for biological safety as well as international regulations. Guidelines are provided for risk assessment, pathogen assessment, biosafety levels, good manufacturing practices, and the roles of various containment barriers.
At the end of this session learner will be able to:
Define Common terms.
Explain the importance of microorganisms control.
Discuss the Methods of sterilization.
Categorize the broad spectrum and narrow spectrum antibiotics.
8. principles of biosafety, biocontainment & program management (nbb160)kckenned
This is an unfortunate example of how failing to follow proper biosafety procedures can put lives at risk. Some key issues:
- Margurita experienced a direct exposure to potentially infectious fluids from a non-human primate, which should have triggered an immediate medical evaluation.
- Her supervisor dismissed the incident instead of ensuring proper exposure follow up per biosafety protocols.
- The delayed onset of symptoms made the link to occupational exposure less clear, but failure to seek timely medical care likely contributed to the tragic outcome.
- All exposures, however minor they seem, must be reported and treated seriously to protect worker health and safety when handling infectious agents. Proper training and oversight can prevent such preventable accidents and protect both
safety data sheet, an introduction to cell culture, safety equipment, safe laboratory practices, ascetic techniques, sterile work area, good personal hygiene, sterile reagents and media, sterile handling, planning of cell culture labs.
Biosafety is the prevention of large-scale loss of biological integrity, focusing both on ecology and human health. These prevention mechanisms include conduction of regular reviews of the biosafety in laboratory settings, as well as strict guidelines to follow. Biosafety also means safety from exposure to infectious agents.
Necessity
In order to avoid infection/biohazard to the laboratory personnel & the environment, biosafety levels are very important.
Safety considerations and guidelines veterinary microbiology laboratoryRavi Kant Agrawal
This document provides guidelines on biosafety and biosecurity for veterinary microbiology laboratories. It defines key terms like biohazard, biosafety, risk assessment, biosecurity, and the biohazard symbol. It discusses the chain of infection and approaches to reduce risk of exposure like risk assessment, personal protective equipment, immunizations, and surveillance. The document also compares and contrasts biosecurity and biosafety. It provides guidance on developing a biosecurity program and addressing breaches. It discusses challenges of preventing interference while ensuring legitimate access.
The document discusses biosafety concepts and practices. It begins by defining biosafety as safety from exposure to infectious agents. It then discusses biosafety issues in various disciplines like agriculture, medicine, and chemistry. The rest of the document outlines biosafety concepts, levels, and practices based on guidance from the Biosafety in Microbiological and Biomedical Laboratories (BMBL) including standard microbiological practices, safety equipment, and facility design requirements for different biosafety levels from BSL-1 to BSL-4. It also discusses risk assessment and containment practices for working with various biological hazards.
Importance of sterilization and its guidelinesRajKumar4943
Sterilization and disinfection are the basic components of hospital infection control activities. Every day, a number of hospitals are performing various surgical procedures. Even more number of invasive procedures are being performed in different health care facilities. The medical device or the surgical instrument that comes in contact with the sterile tissue or the mucus membrane of the patient during the various processes is associated with increased risk of introduction of pathogens into the patient's body. Moreover, there is chance of transmission of infection from patient to patient; from patient or to health care personnel, and vice versa; or from the environment to the patient through the improper sterilized or disinfected devices. Hence, medical personnel, laboratory people and the health care providers should have better knowledge regarding these techniques to prevent the spread of these pathogens.
Physical methods of sterilization include heat, radiation, filtration, and chemical agents. Heat-based methods like autoclaving use high temperatures to kill microbes through protein denaturation. Radiation methods employ UV light or gamma rays which damage microbial DNA. Filtration removes microbes by trapping them in fine pore membranes or filters. Sterilization is important in healthcare and food production to prevent transmission of disease and control microbial growth.
Safety measures, short and accurate pptmeghashridhar
The document discusses safety measures for clinical microbiology laboratories. It emphasizes the importance of lab safety to prevent adverse effects from potential hazards. Good lab practices include proper personal hygiene like handwashing and avoiding eating or drinking in the lab. Labs must follow biosafety guidelines for different levels of microorganisms. Aseptic technique is also important to avoid contamination. Proper clean up and disposal of materials helps maintain safety, such as autoclaving contaminated glassware before disposal.
This document discusses sterilization in dentistry. It defines sterilization as the process of destroying all microbial life from surfaces and instruments using physical and chemical methods. Sterilization is important in dentistry to prevent the spread of infections between patients and dental staff through contaminated instruments. Instruments are classified as critical, semi-critical, or non-critical depending on infection risk. Common sterilization methods discussed are heat (dry and moist), radiation, and chemicals. Monitoring of sterilization includes mechanical, chemical, and biological indicators to ensure the process was effective.
Biochemistry is a basic science which deals with chemical nature and chemical behaviour of living matter and with the reactions and processes they undergo.
Biochemistry involves the study of:
Chemical constituents of living matter.
Chemical changes which occur in the organism during digestion, absorption and excretion.
Chemical changes which occur during growth and multiplication of the organism.
Transformation of one form of chemical constituent to the other.
Energy changes involved in such transformation.
Note:- The term “Biochemistry” was first introduced by German chemist Carl Neuberg in 1903 from Greek word “bios” means “life”.
It is mainly deals with the biochemical aspects that are involved in several conditions.
The results of qualitative and quantitative analysis of body fluids assist the clinicians in the diagnosis, treatment and prevention of the disease and drug monitoring, tissue and organ transplantation, forensic investigations and so on.
Various biological fluids subjected to chemical tests and assays include blood, plasma, serum, urine, cerebrospinal fluid (CSF), ascetic fluid, pleural fluid, faeces, calculi and tissues.
Note:- Modern day medical practice is highly dependent on the laboratory analysis of body fluids, especially the blood. The disease manifestations are reflected in the composition of blood and other tissues.
Hence, the demarcation of abnormal from normal constituents of the body is another aim of the study of clinical biochemistry.
This document discusses sterilization in dentistry. It defines sterilization as the process of destroying all microbial life from surfaces and instruments using physical and chemical methods. Sterilization is important in dentistry to prevent the spread of infections between patients and dental staff through contaminated instruments and surfaces. Instruments are classified as critical, semi-critical, or non-critical depending on infection risk. Common sterilization methods discussed are heat (dry and moist), radiation, and chemicals like phenols, alcohols, aldehydes, and gases. Monitoring of sterilization involves mechanical, chemical, and biological indicators to evaluate effectiveness.
A university researcher died from an infection caused by bacteria he was studying. The bacteria, Yersinia pestis, causes plague. An autopsy found the bacteria in his body but no obvious cause of death. More tests are planned as no other illnesses have been reported. Biosafety aims to reduce risks from exposure to infectious agents through standard practices, containment equipment, facility design and other principles outlined in publications like the Biosafety in Microbiological and Biomedical Laboratories manual. Risk assessments consider the organism, procedures, containment and other factors to determine appropriate biosafety levels and practices.
This document discusses biosafety precautions and laboratory acquired infections. It begins by introducing biosafety and biosafety levels 1 and 2. Biosafety level 1 is for well characterized agents that do not consistently cause disease, while level 2 requires specific training and procedures when working with agents that pose moderate hazards. The document then discusses principles of biosafety like containment and risk assessment. It also provides details on safety equipment, facility design, standard microbiological practices and national biosafety guidelines to prevent laboratory acquired infections.
This document discusses biological and physical hazards. It defines biological hazards as organic substances that threaten health, such as bacteria, viruses, fungi and toxins. It estimates 320,000 workers die annually from work-related biological exposures. Biological hazards enter the body through inhalation, absorption, ingestion, or injection. Engineering, administrative and personal protective controls are used to limit exposure. Radiation can be ionizing (x-rays, gamma rays) or non-ionizing (visible light, radio waves) with ionizing posing health risks like cancer from tissue damage. Sources of ionizing radiation include medical equipment and nuclear reactors/materials.
This document summarizes biosafety guidelines for working with biological materials in a laboratory setting. It describes the various hazards associated with bio research, including hazards from pathogens and laboratory procedures. It provides classifications for pathogens based on their risk level. It also outlines containment procedures like good microbiological techniques, personal protective equipment, and different biosafety levels that should be followed to minimize risk of exposure, depending on the pathogen risk group. The goal is to protect researchers and prevent the spread of infections.
Similar to Bioburden: 4 Facts You Need to Know (20)
How to tell if your fish food is high qualityDocKetchum
- Fish food should contain essential nutrients like amino acids, fatty acids, and carbohydrates to provide energy, structure, and aid in digestion. High quality fish food will contain fish meal, shrimp meal, squid meal, brine shrimp, soybean meal, spirulina algae, and whole wheat as ingredients. Some high quality fish foods recommended are HBH Betta Bites, veggie flakes, cichlid flakes, goldfish flakes, tropical flakes, and African cichlid sinking pellets.
Taking care of a pet turtle requires setting up the proper tank environment including adequate space, heating, and separate land and water areas. Turtles need their temperature regulated between 60-90 degrees F and may hibernate in cooler temperatures. Their diet should mimic what they eat in the wild including vegetables, proteins, and commercial turtle food. It is important to clean the tank regularly and limit handling the turtle to avoid stress, as they can carry salmonella and get hurt easily.
This document summarizes 8 common dental problems: gum disease, cavities, bad breath, oral cancer, receding gum lines, mouth sores, yellow teeth, and teeth grinding. It explains the causes and symptoms of each problem. It emphasizes that visiting the dentist every 6 months is important for prevention and early detection of issues. It promotes a specific dentist in Broomfield, CO for making appointments.
7 Easy Steps for Teaching Your Children How to Brush Their TeethDocKetchum
Are you concerned about your kids' dental health? Do you want to teach them how to properly brush their teeth at a young age? Follow these seven steps to learn some simple ways for teaching your children how to brush their teeth.
Tattoos serve cultural purposes beyond individual expression. Different cultures use tattoos to convey important information like ancestry, rites of passage, religious beliefs, and group affiliation. Tattoo methods vary widely between cultures, from sharpened bamboo in Thailand to facial designs resembling facial hair among the Dulong people of China. Cultural tattoos each carry distinct meanings appropriate to the traditions of groups like the Maori, Thai, Hawaiian, and Hindus.
Sterilization Validation for Medical DevicesDocKetchum
Every medical device produced must be sterilized before being shipped to hospitals, doctors’ offices, and other medical locations.
Random samples of these devices must then be tested to be sure the sterilization kills disease causing microbes including bacteria, fungus, and spores in every device.
These are some of the most common ways that sterilization validation is performed.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
2. What is bioburden?
Bioburden
is the measure of living
microbes on a surface that has not yet
been sterilized.
Most
commonly, bioburden is referenced
when being tested for on medical devices
or objects used in medical care facilities.
3. The
most common microbes tested for in
bioburden are
Yeast
Candida albicans
Bacteria
Escherichia coli (E. coli)
Bacteria
Pseudomonas aeruginosa
Bacteria
Staphylococcus aureus
Fungus
Aspergillua niger
9. Why test for bioburden?
These
microbes, though not usually much
to worry about in normal life, can be
extremely dangerous and life-threatening
if unintentionally inserted into the body
during medical procedures.
By
testing for bioburden, scientists can
determine the most effective ways to
sterilize medical equipment to make them
safe for use.
10. Doctors don’t want to send a sick patient
home with a disease that could have
been prevented from a little sterilization.
11. Who completes bioburden
testing?
The
FDA and International Organization for
Standardization have specific guidelines
that must be followed when testing for
bioburden.
Medical
device companies are required
to perform bioburden testing in house or
hire a lab to perform the tests for them,
such as Nelson Laboratories.
12. During bioburden testing, devices may
be cut up and dismantled to test every
surface of the product.
13. How is bioburden managed?
Medical
device companies perform
bioburden testing on their first run of a
product to determine the necessary
sterilization techniques for all the other
runs.
Random routine testing is performed after
that to ensure that the appropriate
measures are being taken and the
medical devices are truly safe.
14. Time
lapse tests are also performed to see
how often sterilization is required for
certain products.
Scalpels,
catheters, and other frequently
used medical devices are sterilized after
every use. Other devices may only need
to be sterilized once a week or between
uses on different patients.
15. The
are
two primary sterilization methods
Ethylene
Oxide: devices are exposed to
toxic gas, which eliminates hiding
microbes.
Radiation:
gamma rays or X-rays that
penetrate all types of materials (cloth,
metal, plastic, etc.) are used to
eliminate microbes on medical devices.
16. These
sterilization techniques can be
performed at medical care facilities with
the right equipment, or can be sent to a
secondary location to complete the same
procedures.
Either
way, bioburden is eliminated to
prevent harmful infections or diseases to
patients.